Company / Share Buybacks
Emergent BioSolutions Inc. Share Buybacks History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Share Buybacks
$24.9M
FY2025
5-year range
$0 / $106.0M
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#33 of 48
Health Care
What the data says
At $25M, Emergent BioSolutions Inc.'s share buybacks ranks #33 of 48 in the Health Care sector. Improved from $0 to $25M over the past 2 years.
Based on SEC 10-K filings.
$25M in FY2025 with a 3-year CAGR of -32.8%.
Improved from $0 to $25M over the past 2 years.
Health Care sector context is included.
Share Buybacks over time
Growth rates
- 3-Year CAGR
- -32.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#33 of 48 in Health CareTop 69% of 48This company $24.9M Sector average $611.9M
▼
-95.9% below sector average
Key checks
Key Insights
- 3-year CAGR of -32.8%, indicating a declining trend.
- Ranks #33 out of 48 companies in the Health Care sector.
- Peak share buybacks was recorded in FY2021.
- Lowest share buybacks in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Share BuybacksValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $24.9M | - |
| FY2024 | $0 | - |
| FY2023 | $0 | -100.0% |
| FY2022 | $82.1M | -22.5% |
| FY2021 | $106.0M | - |
| FY2020 | $0 | - |
| FY2019 | $0 | - |
| FY2018 | $0 | -100.0% |
| FY2017 | $33.1M | - |
| FY2016 | $0 | -100.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026